Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation

被引:8
作者
Capey, S [1 ]
van den Berg, CW [1 ]
机构
[1] Cardiff Univ, Wales Coll Med, Wales Heart Res Inst, Dept Pharmacol Therapeut & Toxicol, Cardiff CF14 4XN, S Glam, Wales
关键词
atherosclerosis; complement; complement regulators; pig; proliferation; smooth muscle cells; xenotransplantation;
D O I
10.1111/j.1399-3089.2005.00217.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Accelerated atherosclerosis after transplantation has been observed and is characterized by smooth muscle cell proliferation in the graft. Porcine cells are frequently used in models of atherosclerosis and porcine organs are considered for use in transplantation. Complement (C) activation is known to play a major role in rejection of xenografts and is also considered to play a role in the development of atherosclerosis. The aim of this study was to investigate the expression and function of membrane bound regulators of complement (CReg) on porcine aortic smooth muscle cells (PASMC). Methods: The PASMC were assessed for expression of CReg and susceptibility to lysis by human C by flow-cytometry. The effect of various cytokines on CReg expression and C-susceptibility was investigated. The ability of human C to induce cell proliferation was assessed using the Alamar blue assay. Results: The PASMC only express the CReg membrane cofactor protein (MCP) and CD59 on their cell surface. MCP expression was increased by interleukin (IL)-4. In contrast to porcine aortic endothelial cells (PAEC), PASMC were found to be surprisingly sensitive to C-mediated lysis, mainly due to a low level of expression of CD59. Human C-induced proliferation of PASMC, which was dependent on complete membrane attack complex (MAC) formation. Conclusions: Endogenously expressed CReg on PASMC poorly protect these cells to human C. Human C can induce proliferation of PASMC. In order to prevent accelerated atherosclerosis in porcine xenografts, increased levels of CReg not only have to be obtained on the endothelial cells but also on the smooth muscle cells.
引用
收藏
页码:217 / 226
页数:10
相关论文
共 33 条
[1]   A NEW RAPID AND SIMPLE NONRADIOACTIVE ASSAY TO MONITOR AND DETERMINE THE PROLIFERATION OF LYMPHOCYTES - AN ALTERNATIVE TO [H-3] THYMIDINE INCORPORATION ASSAY [J].
AHMED, SA ;
GOGAL, RM ;
WALSH, JE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 170 (02) :211-224
[2]   RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase [J].
Badea, T ;
Niculescu, F ;
Soane, L ;
Fosbrink, M ;
Sorana, H ;
Rus, V ;
Shin, ML ;
Rus, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) :502-508
[3]   Characterization of pigs transgenic for human decay-accelerating factor [J].
Cozzi, E ;
Tucker, AW ;
Langford, GA ;
PinoChavez, G ;
Wright, L ;
OConnell, MJ ;
Young, VJ ;
Lancaster, R ;
McLaughlin, M ;
Hunt, K ;
Bordin, MC ;
White, DJG .
TRANSPLANTATION, 1997, 64 (10) :1383-1392
[4]   Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a galα(1-3)gal binding lectin:: Up-regulation of CD59 expression [J].
Dalmasso, AP ;
Benson, BA ;
Johnson, JS ;
Lancto, C ;
Abrahamsen, MS .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3764-3773
[5]  
De la Lastra JMP, 1999, IMMUNOLOGY, V98, P144
[6]  
De la Lastra JMP, 1999, IMMUNOLOGY, V96, P663
[7]   Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats [J].
de la Lastra, JMP ;
Harris, CL ;
Hinchliffe, SJ ;
Holt, DS ;
Rushmere, NK ;
Morgan, BP .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2563-2573
[8]   THE INFLUENCE OF STEROLS ON THE SENSITIVITY OF LIPID BILAYERS TO MELITTIN [J].
FEIGIN, AM ;
TEETER, JH ;
BRAND, JG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 211 (01) :312-317
[9]   Characteristics of CD59 up-regulation induced in porcine endothelial cells by αGal ligation and its association with protection from complement [J].
Grubbs, BC ;
Benson, BA ;
Dalmasso, AP .
XENOTRANSPLANTATION, 2003, 10 (05) :387-397
[10]  
Hanna SM, 1998, IMMUNOLOGY, V95, P450